Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA email: rustgi@helix.mgh.harvard.edu
A new generation of NSAIDs selectively and irreversibly inhibits cyclooxygenase-2—an enzyme that regulates several cellular processes involved in colon cancer development including angiogenesis.
REFERENCES
Giardiello, F.M. et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N, Engl. J. Med.328, 1313−1316 (1993). | Article | PubMed | ISI | ChemPort |
Sniff, S.J. & Rigas, B. Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Castroenterology113, 1992−1998 (1998).
Piazza, G.A. et al. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res.57, 2909−2915 (1997). | PubMed | ISI | ChemPort |
Oshima, M. et al. Suppression of intestinal polyposis in APC delta 716 knockout mice by inhibition of prostaglandin endoperoxidase-2 (COX-2). Cell87, 803−809 (1996). | Article | PubMed | ISI | ChemPort |
Sheng, H. et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest.99, 2254−2259 (1997). | PubMed | ISI | ChemPort |
Reddy B.S., Rao, C.V. & Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res.56, 4566−4569 (1996). | PubMed | ISI | ChemPort |
Tsujii, M. & DuBois, R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell83, 493−501 (1995). | Article | PubMed | ISI | ChemPort |
Tsujii, M., Kuwano, S. & sDuBois, R.N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA94, 3336−3340 (1997). | Article | PubMed | ChemPort |
Tsujii, M. et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell93, 705−716 (1998). | Article | PubMed | ISI | ChemPort |
